2018 Q4 Form 10-Q Financial Statement

#000117992918000189 Filed on November 01, 2018

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2017 Q3
Revenue $4.664B $4.697B $5.031B
YoY Change -5.76% -6.64% 10.67%
Cost Of Revenue $3.790B $3.901B $4.343B
YoY Change -13.35% -10.18% 12.31%
Gross Profit $664.0M $566.0M $564.0M
YoY Change 48.88% 0.35% 19.75%
Gross Profit Margin 14.24% 12.05% 11.21%
Selling, General & Admin $519.0M $508.0M $489.0M
YoY Change 9.49% 3.89% -6.86%
% of Gross Profit 78.16% 89.75% 86.7%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $23.00M $31.00M $43.00M
YoY Change -41.03% -27.91% -6.52%
% of Gross Profit 3.46% 5.48% 7.62%
Operating Expenses $542.0M $533.0M $522.0M
YoY Change 7.97% 2.11% -6.95%
Operating Profit $122.0M $295.0M -$81.00M
YoY Change -317.86% -464.2% -168.64%
Interest Expense -$24.00M $26.00M $32.00M
YoY Change -27.27% -18.75% 23.08%
% of Operating Profit -19.67% 8.81%
Other Income/Expense, Net $5.000M -$36.00M -$32.00M
YoY Change -135.71% 12.5% 23.08%
Pretax Income $256.0M $259.0M -$113.0M
YoY Change -181.01% -329.2% -222.83%
Income Tax $55.00M $62.00M -$16.00M
% Of Pretax Income 21.48% 23.94%
Net Earnings $201.0M $197.0M -$97.00M
YoY Change -176.72% -303.09% -330.95%
Net Earnings / Revenue 4.31% 4.19% -1.93%
Basic Earnings Per Share $3.24 $3.22 -$1.70
Diluted Earnings Per Share $3.01 $2.90 -$1.70
COMMON SHARES
Basic Shares Outstanding 62.39M shares 61.30M shares 56.50M shares
Diluted Shares Outstanding 67.90M shares 56.50M shares

Balance Sheet

Concept 2018 Q4 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.507B $4.626B $5.721B
YoY Change -21.07% -19.14% 24.99%
Cash & Equivalents $2.826B $2.814B $3.934B
Short-Term Investments $1.681B $1.812B $1.787B
Other Short-Term Assets $625.0M $1.329B $925.0M
YoY Change -28.65% 43.68% 91.51%
Inventory
Prepaid Expenses
Receivables $1.330B $1.346B $1.002B
Other Receivables $0.00 $0.00 $60.00M
Total Short-Term Assets $6.462B $7.301B $7.708B
YoY Change -13.97% -5.28% 26.09%
LONG-TERM ASSETS
Property, Plant & Equipment $241.0M $264.0M $397.0M
YoY Change -29.53% -33.5% -11.78%
Goodwill $143.0M $430.0M
YoY Change -23.12% -30.53%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $24.00M $30.00M $42.00M
YoY Change -82.98% -28.57% 5.0%
Total Long-Term Assets $692.0M $750.0M $1.246B
YoY Change -27.92% -39.81% -14.48%
TOTAL ASSETS
Total Short-Term Assets $6.462B $7.301B $7.708B
Total Long-Term Assets $692.0M $750.0M $1.246B
Total Assets $7.154B $8.051B $8.954B
YoY Change -15.55% -10.08% 18.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $390.0M $824.0M $485.0M
YoY Change 6.56% 69.9% 26.63%
Accrued Expenses
YoY Change
Deferred Revenue $211.0M $178.0M
YoY Change -25.18%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $241.0M $296.0M $782.0M
YoY Change -63.09% -62.15% 67.81%
Total Short-Term Liabilities $4.246B $5.213B $5.962B
YoY Change -23.59% -12.56% 27.8%
LONG-TERM LIABILITIES
Long-Term Debt $1.020B $1.019B $1.317B
YoY Change -22.61% -22.63% 12.66%
Other Long-Term Liabilities $44.00M $60.00M $48.00M
YoY Change -27.87% 25.0% 23.08%
Total Long-Term Liabilities $1.064B $1.079B $1.365B
YoY Change -22.84% -20.95% 13.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.246B $5.213B $5.962B
Total Long-Term Liabilities $1.064B $1.079B $1.365B
Total Liabilities $5.507B $6.490B $7.525B
YoY Change -22.81% -13.75% 28.0%
SHAREHOLDERS EQUITY
Retained Earnings $1.012B $811.0M $560.0M
YoY Change 239.6% 44.82% -34.66%
Common Stock $643.0M $760.0M $870.0M
YoY Change -38.41% -12.64% 4.69%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.647B $1.561B $1.429B
YoY Change
Total Liabilities & Shareholders Equity $7.154B $8.051B $8.954B
YoY Change -15.55% -10.08% 18.28%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income $201.0M $197.0M -$97.00M
YoY Change -176.72% -303.09% -330.95%
Depreciation, Depletion And Amortization $23.00M $31.00M $43.00M
YoY Change -41.03% -27.91% -6.52%
Cash From Operating Activities -$123.0M -$505.0M $285.0M
YoY Change -19.61% -277.19% -19.72%
INVESTING ACTIVITIES
Capital Expenditures -$6.000M -$10.00M -$25.00M
YoY Change 500.0% -60.0% -39.02%
Acquisitions
YoY Change
Other Investing Activities $328.0M $433.0M $396.0M
YoY Change -155.88% 9.34% 116.39%
Cash From Investing Activities $322.0M $423.0M $371.0M
YoY Change -154.76% 14.02% 161.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -181.0M -509.0M 299.0M
YoY Change -4625.0% -270.23%
NET CHANGE
Cash From Operating Activities -123.0M -505.0M 285.0M
Cash From Investing Activities 322.0M 423.0M 371.0M
Cash From Financing Activities -181.0M -509.0M 299.0M
Net Change In Cash 18.00M -591.0M 955.0M
YoY Change -102.44% -161.88% 92.15%
FREE CASH FLOW
Cash From Operating Activities -$123.0M -$505.0M $285.0M
Capital Expenditures -$6.000M -$10.00M -$25.00M
Free Cash Flow -$117.0M -$495.0M $310.0M
YoY Change -23.03% -259.68% -21.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Trading Symbol
TradingSymbol
moh
dei Entity Central Index Key
EntityCentralIndexKey
0001179929
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Period End Date
DocumentPeriodEndDate
2018-09-30
dei Document Type
DocumentType
10-Q
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
62389000 shares
us-gaap Notes Issued1
NotesIssued1
0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
63.67
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
566544 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
73.85
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
MOLINA HEALTHCARE INC
dei Entity Small Business
EntitySmallBusiness
false
CY2018Q3 moh Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable
AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayable
-390000000 USD
moh Amortization Of Debt Discount Premium And Sale Leaseback Financing Obligation
AmortizationOfDebtDiscountPremiumAndSaleLeasebackFinancingObligation
24000000 USD
CY2018Q3 moh Additional Medical Care Costs Incurred
AdditionalMedicalCareCostsIncurred
5000000 USD
CY2017Q4 moh Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable
AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayable
-912000000 USD
moh Gain Losson Dispositionof Liabilities
GainLossonDispositionofLiabilities
59000000 USD
moh Amortization Of Debt Discount Premium And Sale Leaseback Financing Obligation
AmortizationOfDebtDiscountPremiumAndSaleLeasebackFinancingObligation
18000000 USD
CY2017Q3 moh Amount Of Current Year Quality Incentive Premium Revenue Recognized
AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized
24000000 USD
moh Amount Of Current Year Quality Incentive Premium Revenue Recognized
AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized
72000000 USD
CY2018Q3 moh Amount Of Current Year Quality Incentive Premium Revenue Recognized
AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized
39000000 USD
moh Amount Of Current Year Quality Incentive Premium Revenue Recognized
AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized
97000000 USD
CY2017Q3 moh Amount Of Quality Incentive Premium Revenue Recognized From Prior Year
AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear
3000000 USD
moh Amount Of Quality Incentive Premium Revenue Recognized From Prior Year
AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear
9000000 USD
CY2018Q3 moh Amount Of Quality Incentive Premium Revenue Recognized From Prior Year
AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear
9000000 USD
moh Amount Of Quality Incentive Premium Revenue Recognized From Prior Year
AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear
32000000 USD
CY2017Q3 moh Antidilutive Securities Excludedfrom Computationof Earnings Per Share Share Based Compensation Amount
AntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareShareBasedCompensationAmount
200000 shares
moh Antidilutive Securities Excludedfrom Computationof Earnings Per Share Share Based Compensation Amount
AntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareShareBasedCompensationAmount
300000 shares
CY2018Q3 moh Antidilutive Securities Excludedfrom Computationof Earnings Per Share Share Based Compensation Amount
AntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareShareBasedCompensationAmount
0 shares
moh Antidilutive Securities Excludedfrom Computationof Earnings Per Share Share Based Compensation Amount
AntidilutiveSecuritiesExcludedfromComputationofEarningsPerShareShareBasedCompensationAmount
0 shares
moh Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0 USD
moh Capital Contributions To Subsidiaries
CapitalContributionsToSubsidiaries
0 USD
CY2017Q4 moh Capitation Claims Payable
CapitationClaimsPayable
67000000 USD
CY2018Q3 moh Capitation Claims Payable
CapitationClaimsPayable
48000000 USD
moh Cash Paid For Settlement Of Conversion Option
CashPaidForSettlementOfConversionOption
0 USD
moh Cash Paid For Settlement Of Conversion Option
CashPaidForSettlementOfConversionOption
477000000 USD
moh Changes In Amounts Due To And Due From Affiliates
ChangesInAmountsDueToAndDueFromAffiliates
0 USD
moh Changes In Amounts Due To And Due From Affiliates
ChangesInAmountsDueToAndDueFromAffiliates
0 USD
moh Dispositionof Business Receivablefrom Buyer
DispositionofBusinessReceivablefromBuyer
0 USD
moh Dispositionof Business Receivablefrom Buyer
DispositionofBusinessReceivablefromBuyer
233000000 USD
moh Dispositionof Business Transaction Costs
DispositionofBusinessTransactionCosts
0 USD
moh Dispositionof Business Transaction Costs
DispositionofBusinessTransactionCosts
12000000 USD
moh Dividends From Subsidiaries
DividendsFromSubsidiaries
0 USD
moh Dividends From Subsidiaries
DividendsFromSubsidiaries
0 USD
moh Gain Losson Dispositionof Liabilities
GainLossonDispositionofLiabilities
0 USD
CY2017Q3 moh Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
0 USD
moh Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
0 USD
CY2018Q3 moh Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
87000000 USD
moh Health Care Organization Insurer Fee Expense
HealthCareOrganizationInsurerFeeExpense
261000000 USD
CY2017Q3 moh Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
0 USD
moh Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
0 USD
CY2018Q3 moh Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
83000000 USD
moh Health Care Organization Insurer Fee Revenue
HealthCareOrganizationInsurerFeeRevenue
248000000 USD
CY2017Q3 moh Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
106000000 USD
moh Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
331000000 USD
CY2018Q3 moh Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
110000000 USD
moh Health Care Organization Premium Tax Revenue
HealthCareOrganizationPremiumTaxRevenue
320000000 USD
moh Increase Decrease In Medical Premium Liability Due To Agency
IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency
122000000 USD
moh Increase Decrease In Medical Premium Liability Due To Agency
IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency
-511000000 USD
moh Increase Decreasein Carrying Amountof Assets
IncreaseDecreaseinCarryingAmountofAssets
0 USD
moh Increase Decreasein Carrying Amountof Assets
IncreaseDecreaseinCarryingAmountofAssets
-243000000 USD
moh Investments Average Maturity Period
InvestmentsAverageMaturityPeriod
P3Y
moh Investments Maturity Period
InvestmentsMaturityPeriod
P10Y
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10000000 USD
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1044000000 USD
CY2017Q3 moh Maximum Available Quality Incentive Premium Current Year
MaximumAvailableQualityIncentivePremiumCurrentYear
36000000 USD
moh Maximum Available Quality Incentive Premium Current Year
MaximumAvailableQualityIncentivePremiumCurrentYear
113000000 USD
CY2018Q3 moh Maximum Available Quality Incentive Premium Current Year
MaximumAvailableQualityIncentivePremiumCurrentYear
48000000 USD
moh Maximum Available Quality Incentive Premium Current Year
MaximumAvailableQualityIncentivePremiumCurrentYear
135000000 USD
CY2017Q4 moh Medical Claims And Benefits Payable
MedicalClaimsAndBenefitsPayable
122000000 USD
CY2018Q3 moh Medical Claims And Benefits Payable
MedicalClaimsAndBenefitsPayable
158000000 USD
moh Medical Claims And Benefits Payable Adjustments Change In Provider
MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider
172000000 USD
moh Medical Claims And Benefits Payable Adjustments Change In Provider
MedicalClaimsAndBenefitsPayableAdjustmentsChangeInProvider
60000000 USD
CY2017Q4 moh Medical Premium Liability Due To Agency
MedicalPremiumLiabilityDueToAgency
1542000000 USD
CY2018Q3 moh Medical Premium Liability Due To Agency
MedicalPremiumLiabilityDueToAgency
1030000000 USD
CY2017Q3 moh Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
-97000000 USD
moh Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
-250000000 USD
CY2018Q3 moh Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
197000000 USD
moh Net Income Loss From Continuing Operations Before Equity Method Investments Extraordinary Items Noncontrolling Interest
NetIncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsExtraordinaryItemsNoncontrollingInterest
506000000 USD
moh Noncash Restructuring Charges
NoncashRestructuringCharges
49000000 USD
moh Noncash Restructuring Charges
NoncashRestructuringCharges
17000000 USD
moh Notes Issued Fair Value Adjustment Increase Decrease
NotesIssuedFairValueAdjustmentIncreaseDecrease
0 USD
moh Notes Issued Fair Value Adjustment Increase Decrease
NotesIssuedFairValueAdjustmentIncreaseDecrease
-23000000 USD
CY2017Q4 moh Other Claims Payable
OtherClaimsPayable
296000000 USD
CY2018Q3 moh Other Claims Payable
OtherClaimsPayable
264000000 USD
CY2017Q4 moh Pharmacy Claims Payable
PharmacyClaimsPayable
112000000 USD
CY2018Q3 moh Pharmacy Claims Payable
PharmacyClaimsPayable
121000000 USD
CY2017Q3 moh Premium Tax Expenses
PremiumTaxExpenses
106000000 USD
moh Premium Tax Expenses
PremiumTaxExpenses
331000000 USD
CY2018Q3 moh Premium Tax Expenses
PremiumTaxExpenses
110000000 USD
moh Premium Tax Expenses
PremiumTaxExpenses
320000000 USD
CY2017Q3 moh Quality Incentive Premium Revenue As A Percentage Of Total Revenue
QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue
0.006
moh Quality Incentive Premium Revenue As A Percentage Of Total Revenue
QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue
0.006
CY2018Q3 moh Quality Incentive Premium Revenue As A Percentage Of Total Revenue
QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue
0.011
moh Quality Incentive Premium Revenue As A Percentage Of Total Revenue
QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue
0.010
CY2017Q3 moh Quality Incentive Premium Revenue Recognized
QualityIncentivePremiumRevenueRecognized
27000000 USD
moh Quality Incentive Premium Revenue Recognized
QualityIncentivePremiumRevenueRecognized
81000000 USD
CY2018Q3 moh Quality Incentive Premium Revenue Recognized
QualityIncentivePremiumRevenueRecognized
48000000 USD
moh Quality Incentive Premium Revenue Recognized
QualityIncentivePremiumRevenueRecognized
129000000 USD
moh Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue
35000000 USD
moh Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted In Period Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue
42000000 USD
CY2018Q3 moh Tax Cuts And Jobs Act Of2017 Change In Tax Rate Deferred Tax Asset Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateDeferredTaxAssetIncomeTaxExpenseBenefit
4000000 USD
moh Unrecognized Compensation Forfeited Rate
UnrecognizedCompensationForfeitedRate
0.121
CY2017Q3 moh Weighted Average Numberof Shares Share Based Compensation
WeightedAverageNumberofSharesShareBasedCompensation
0 shares
moh Weighted Average Numberof Shares Share Based Compensation
WeightedAverageNumberofSharesShareBasedCompensation
400000 shares
CY2018Q3 moh Weighted Average Numberof Shares Share Based Compensation
WeightedAverageNumberofSharesShareBasedCompensation
0 shares
moh Weighted Average Numberof Shares Share Based Compensation
WeightedAverageNumberofSharesShareBasedCompensation
200000 shares
CY2017Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
366000000 USD
CY2018Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
824000000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5000000 USD
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
760000000 USD
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
0 USD
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
108000000 USD
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
4000000 USD
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-113000000 USD
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
108000000 USD
CY2017Q4 us-gaap Assets
Assets
8471000000 USD
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-306000000 USD
CY2017Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
8000000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
24000000 USD
CY2018Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
5000000 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
18000000 USD
CY2017Q4 us-gaap Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
1691000000 USD
CY2018Q3 us-gaap Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries
AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries
2041000000 USD
CY2018Q3 us-gaap Assets
Assets
8051000000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
7511000000 USD
CY2018Q3 us-gaap Assets Current
AssetsCurrent
7301000000 USD
CY2017Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
3215000000 USD
CY2018Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2655000000 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2700000000 USD
CY2018Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1824000000 USD
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
2693000000 USD
CY2018Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
1812000000 USD
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000000 USD
CY2018Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000000 USD
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
8000000 USD
CY2018Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
13000000 USD
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
3000000 USD
CY2018Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
7000000 USD
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
5000000 USD
CY2018Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
6000000 USD
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
1940000000 USD
CY2018Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
862000000 USD
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
227000000 USD
CY2018Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
462000000 USD
CY2018Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
799000000 USD
CY2018Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
789000000 USD
CY2018Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
1025000000 USD
CY2018Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
1023000000 USD
CY2018Q3 us-gaap Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
1812000000 USD
CY2017Q4 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
719 Security
CY2018Q3 us-gaap Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year
AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear
564 Security
CY2017Q4 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
164 Security
CY2018Q3 us-gaap Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year
AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear
283 Security
CY2017Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
1000000 USD
CY2018Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
1000000 USD
CY2017Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
198000000 USD
CY2018Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
198000000 USD
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3934000000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3186000000 USD
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2814000000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2912000000 USD
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4025000000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3290000000 USD
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2908000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1113000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-382000000 USD
CY2013Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
53.8475
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
60000000 shares
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62000000 shares
CY2017Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
0 USD
CY2018Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
0 USD
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-97000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-249000000 USD
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
198000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
502000000 USD
CY2017Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
282000000 USD
CY2018Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
178000000 USD
CY2017Q3 us-gaap Costs And Expenses
CostsAndExpenses
5112000000 USD
us-gaap Costs And Expenses
CostsAndExpenses
15220000000 USD
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
4439000000 USD
us-gaap Costs And Expenses
CostsAndExpenses
13404000000 USD
CY2018Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
21000000 USD
CY2018Q3 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
37000000 USD
CY2013 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
13490236 shares
CY2018Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1344000000 USD
CY2017Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
4000000 USD
CY2018Q3 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
1000000 USD
CY2017Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
12000000 USD
CY2018Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
11000000 USD
CY2017Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
103000000 USD
CY2018Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
143000000 USD
CY2017Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
0 USD
CY2017Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
33000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
109000000 USD
CY2018Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
25000000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
76000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
139000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
104000000 USD
CY2017Q4 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
522000000 USD
CY2018Q3 us-gaap Derivative Assets Current
DerivativeAssetsCurrent
843000000 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 USD
CY2017Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
522000000 USD
CY2018Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
843000000 USD
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.70
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.44
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
8.32
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.70
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.44
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.60
CY2018Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
41000000 USD
CY2017Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2018Q3 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
37000000 USD
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
37000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-25000000 USD
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
383000000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1227000000 USD
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
311000000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
998000000 USD
CY2017Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
129000000 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
201000000 USD
CY2018Q3 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2018Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
118000000 USD
CY2018Q3 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
7000000 USD
CY2018Q3 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
7000000 USD
CY2018Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
111000000 USD
CY2018Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
111000000 USD
CY2018Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
118000000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-113000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-296000000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
259000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
743000000 USD
CY2017Q3 us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
0 USD
us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
0 USD
CY2018Q3 us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
0 USD
us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
0 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-16000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-46000000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
62000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
237000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
90000000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
398000000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-22000000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
118000000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
153000000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-55000000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
68000000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
32000000 USD
us-gaap Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
549000000 USD
us-gaap Increase Decrease In Health Care Insurance Liabilities
IncreaseDecreaseInHealthCareInsuranceLiabilities
-144000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
53000000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
117000000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
28000000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
507000000 USD
CY2017Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2018Q3 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
5600000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
5000000 shares
CY2017Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2018Q3 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
600000 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
500000 shares
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2018Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
400000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
300000 shares
CY2017Q3 us-gaap Insurance Services Revenue
InsuranceServicesRevenue
130000000 USD
us-gaap Insurance Services Revenue
InsuranceServicesRevenue
390000000 USD
CY2018Q3 us-gaap Insurance Services Revenue
InsuranceServicesRevenue
130000000 USD
us-gaap Insurance Services Revenue
InsuranceServicesRevenue
391000000 USD
CY2017Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
255000000 USD
CY2018Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
195000000 USD
CY2017Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
18000000 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
48000000 USD
CY2018Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
37000000 USD
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
93000000 USD
CY2017Q3 us-gaap Interest Expense
InterestExpense
32000000 USD
us-gaap Interest Expense
InterestExpense
85000000 USD
CY2018Q3 us-gaap Interest Expense
InterestExpense
26000000 USD
us-gaap Interest Expense
InterestExpense
91000000 USD
CY2017Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
11000000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
33000000 USD
CY2018Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
6000000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
23000000 USD
CY2017Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
3000000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
9000000 USD
CY2018Q3 us-gaap Liabilities
Liabilities
6490000000 USD
CY2018Q3 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
1000000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
5000000 USD
CY2017Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0 USD
CY2018Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0 USD
CY2017Q4 us-gaap Liabilities
Liabilities
7134000000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8471000000 USD
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8051000000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5557000000 USD
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5213000000 USD
CY2017Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
522000000 USD
CY2018Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
843000000 USD
CY2016Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
1929000000 USD
CY2017Q3 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
2478000000 USD
CY2017Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
2192000000 USD
CY2018Q3 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
2042000000 USD
us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
10944000000 USD
us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
9866000000 USD
us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
1501000000 USD
us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
1706000000 USD
CY2017Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
1717000000 USD
CY2018Q3 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
1609000000 USD
us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
12822000000 USD
us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
11362000000 USD
CY2017Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1516000000 USD
CY2018Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
1217000000 USD
CY2017Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
653000000 USD
CY2018Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
296000000 USD
CY2017Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
2169000000 USD
CY2018Q3 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
1513000000 USD
CY2018Q3 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
330000000 USD
CY2018Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0 USD
CY2018Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0 USD
CY2018Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
700000000 USD
CY2018Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 USD
CY2018Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
314000000 USD
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1318000000 USD
CY2018Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1019000000 USD
CY2017Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
2524000000 USD
CY2018Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1812000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
632000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1012000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-476000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
821000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
957000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-191000000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
77000000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-230000000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-97000000 USD
us-gaap Net Income Loss
NetIncomeLoss
-250000000 USD
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
107000000 USD
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
202000000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
197000000 USD
us-gaap Net Income Loss
NetIncomeLoss
506000000 USD
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-32000000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10000000 USD
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-36000000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-116000000 USD
us-gaap Notes Issued1
NotesIssued1
131000000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segment
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-81000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-286000000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
295000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
859000000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
141000000 USD
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
30000000 USD
CY2017Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000000 USD
CY2017Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000000 USD
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6000000 USD
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000000 USD
CY2018Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4000000 USD
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1000000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
2000000 USD
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
1000000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-5000000 USD
CY2017Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
1000000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
1000000 USD
CY2018Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
0 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-1000000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
61000000 USD
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
60000000 USD
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
75000000 USD
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-25000000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
13000000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
6000000 USD
us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
12445000000 USD
us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
11572000000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
33000000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
23000000 USD
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
0 USD
us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
419000000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
32000000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1894000000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
1202000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
85000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24000000 USD
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2018Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q3 us-gaap Premiums Earned Net
PremiumsEarnedNet
4777000000 USD
us-gaap Premiums Earned Net
PremiumsEarnedNet
14165000000 USD
CY2018Q3 us-gaap Premiums Earned Net
PremiumsEarnedNet
4337000000 USD
us-gaap Premiums Earned Net
PremiumsEarnedNet
13174000000 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
239000000 USD
CY2018Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
486000000 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
477000000 USD
us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
325000000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
325000000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
300000000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
7000000 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
7000000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1536000000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2070000000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
342000000 USD
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
264000000 USD
CY2017Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
871000000 USD
CY2018Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
1346000000 USD
CY2017Q4 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
0 USD
CY2018Q3 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
0 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
300000000 USD
CY2017Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
91000000 USD
CY2018Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
94000000 USD
CY2017Q4 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
169000000 USD
CY2018Q3 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
0 USD
CY2017Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
119000000 USD
CY2018Q3 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
118000000 USD
us-gaap Restructuring Charges
RestructuringCharges
8000000 USD
CY2017Q3 us-gaap Restructuring Costs
RestructuringCosts
118000000 USD
us-gaap Restructuring Costs
RestructuringCosts
161000000 USD
CY2018Q3 us-gaap Restructuring Costs
RestructuringCosts
5000000 USD
us-gaap Restructuring Costs
RestructuringCosts
38000000 USD
CY2017Q4 us-gaap Restructuring Reserve
RestructuringReserve
48000000 USD
CY2018Q3 us-gaap Restructuring Reserve
RestructuringReserve
33000000 USD
us-gaap Restructuring Reserve Accrual Adjustment1
RestructuringReserveAccrualAdjustment1
9000000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
298000000 USD
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
811000000 USD
CY2017Q3 us-gaap Revenues
Revenues
5031000000 USD
us-gaap Revenues
Revenues
14934000000 USD
CY2018Q3 us-gaap Revenues
Revenues
4697000000 USD
us-gaap Revenues
Revenues
14226000000 USD
CY2017Q3 us-gaap Share Based Compensation
ShareBasedCompensation
3000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
38000000 USD
CY2018Q3 us-gaap Share Based Compensation
ShareBasedCompensation
7000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
20000000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
305471 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
578394 shares
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
617584 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
58.35
CY2018Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
70.11
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
221883 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
45000000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
17000000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
57.87
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2016Q4 us-gaap Shares Outstanding
SharesOutstanding
55800000 shares
CY2017Q2 us-gaap Shares Outstanding
SharesOutstanding
56500000 shares
CY2017Q4 us-gaap Shares Outstanding
SharesOutstanding
59300000 shares
CY2018Q2 us-gaap Shares Outstanding
SharesOutstanding
61300000 shares
CY2018Q3 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Balance
StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
2125000000 USD
CY2018Q3 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Required
StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
1138000000 USD
us-gaap Stock Issued1
StockIssued1
21000000 USD
us-gaap Stock Issued1
StockIssued1
6000000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
CY2017Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
24000000 USD
CY2017Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5000000 USD
CY2018Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1000000 USD
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56500000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56200000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61300000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
60800000 shares
CY2018Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
15000000 USD
CY2018Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7000000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
1337000000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
1561000000 USD
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1649000000 USD
CY2017Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1727000000 USD
CY2017Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1521000000 USD
CY2017Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1429000000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1337000000 USD
CY2018Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1553000000 USD
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1658000000 USD
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1561000000 USD
us-gaap Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
12813000000 USD
us-gaap Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
11589000000 USD
us-gaap Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
9000000 USD
us-gaap Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
-227000000 USD
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56200000 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
67900000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
66600000 shares
CY2017Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
0 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
0 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
0 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
1300000 shares
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Presentation and Reclassification</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We have reclassified certain amounts in the 2017 consolidated statement of cash flows to conform to the 2018 presentation, relating to the presentation of restricted cash and cash equivalents. The reclassification is a result of our adoption of Accounting Standards Update (ASU) 2016-18,</font><font style="font-family:Arial;font-size:10pt;font-style:italic;"> Restricted Cash </font><font style="font-family:Arial;font-size:10pt;">effective January 1, 2018. See Note </font><font style="font-family:Arial;font-size:10pt;font-style:normal;font-weight:normal;">2</font><font style="font-family:Arial;font-size:10pt;">, &#8220;</font><font style="font-family:Arial;font-size:10pt;">Significant Accounting Policies</font><font style="font-family:Arial;font-size:10pt;">,&#8221; for further information, including the amount reclassified.</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We have combined certain line items in the accompanying consolidated balance sheets. For all periods presented, we have combined the presentation of:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Income taxes refundable with &#8220;Prepaid expenses and other current assets;&#8221;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Income taxes payable with &#8220;Accounts payable and accrued liabilities;&#8221;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Goodwill, and intangible assets, net to a single line; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Deferred contract costs with &#8220;Other assets.&#8221;</font></div></td></tr></table></div>
us-gaap Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense
ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table provides the details of our medical claims and benefits payable (including amounts payable for the provision of long-term services and supports, or LTSS) as of the dates indicated:</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">September&#160;30, <br clear="none"/>2018</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">December&#160;31,<br clear="none"/>2017</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">(In millions)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Fee-for-service claims incurred but not paid (IBNP)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,609</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,717</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Pharmacy payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">121</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">112</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Capitation payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">48</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">67</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">264</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">296</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,042</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2,192</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

Files In Submission

Name View Source Status
0001179929-18-000189-index-headers.html Edgar Link pending
0001179929-18-000189-index.html Edgar Link pending
0001179929-18-000189.txt Edgar Link pending
0001179929-18-000189-xbrl.zip Edgar Link pending
chart-c2852640589f52219c9.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
moh-09302018x10q.htm Edgar Link pending
moh-09302018xex311.htm Edgar Link pending
moh-09302018xex312.htm Edgar Link pending
moh-09302018xex321.htm Edgar Link pending
moh-09302018xex322.htm Edgar Link pending
moh-20180930.xml Edgar Link completed
moh-20180930.xsd Edgar Link pending
moh-20180930_cal.xml Edgar Link unprocessable
moh-20180930_def.xml Edgar Link unprocessable
moh-20180930_lab.xml Edgar Link unprocessable
moh-20180930_pre.xml Edgar Link unprocessable
moh09302018exhibit21.htm Edgar Link pending
moh09302018exhibit21001.jpg Edgar Link pending
moh09302018exhibit21002.jpg Edgar Link pending
moh09302018exhibit21003.jpg Edgar Link pending
moh09302018exhibit21004.jpg Edgar Link pending
moh09302018exhibit21005.jpg Edgar Link pending
moh09302018exhibit21006.jpg Edgar Link pending
moh09302018exhibit21007.jpg Edgar Link pending
moh09302018exhibit21008.jpg Edgar Link pending
moh09302018exhibit21009.jpg Edgar Link pending
moh09302018exhibit21010.jpg Edgar Link pending
moh09302018exhibit21011.jpg Edgar Link pending
moh09302018exhibit21012.jpg Edgar Link pending
moh09302018exhibit21013.jpg Edgar Link pending
moh09302018exhibit21014.jpg Edgar Link pending
moh09302018exhibit21015.jpg Edgar Link pending
moh09302018exhibit21016.jpg Edgar Link pending
moh09302018exhibit21017.jpg Edgar Link pending
moh09302018exhibit21018.jpg Edgar Link pending
moh09302018exhibit21019.jpg Edgar Link pending
moh09302018exhibit21020.jpg Edgar Link pending
moh09302018exhibit21021.jpg Edgar Link pending
moh09302018exhibit21022.jpg Edgar Link pending
moh09302018exhibit21023.jpg Edgar Link pending
moh09302018exhibit21024.jpg Edgar Link pending
moh09302018exhibit21025.jpg Edgar Link pending
moh09302018exhibit21026.jpg Edgar Link pending
moh09302018exhibit21027.jpg Edgar Link pending
moh09302018exhibit21028.jpg Edgar Link pending
moh09302018exhibit21029.jpg Edgar Link pending
moh09302018exhibit21030.jpg Edgar Link pending
moh09302018exhibit21031.jpg Edgar Link pending
moh09302018exhibit21032.jpg Edgar Link pending
moh09302018exhibit21033.jpg Edgar Link pending
moh09302018exhibit21034.jpg Edgar Link pending
moh09302018exhibit21035.jpg Edgar Link pending
moh09302018exhibit21036.jpg Edgar Link pending
moh09302018exhibit21037.jpg Edgar Link pending
moh09302018exhibit21038.jpg Edgar Link pending
moh09302018exhibit21039.jpg Edgar Link pending
moh09302018exhibit21040.jpg Edgar Link pending
moh09302018exhibit21041.jpg Edgar Link pending
moh09302018exhibit21042.jpg Edgar Link pending
moh09302018exhibit21043.jpg Edgar Link pending
moh09302018exhibit21044.jpg Edgar Link pending
moh09302018exhibit21045.jpg Edgar Link pending
moh09302018exhibit21046.jpg Edgar Link pending
moh09302018exhibit21047.jpg Edgar Link pending
moh09302018exhibit21048.jpg Edgar Link pending
moh09302018exhibit21049.jpg Edgar Link pending
moh09302018exhibit21050.jpg Edgar Link pending
moh09302018exhibit21051.jpg Edgar Link pending
moh09302018exhibit21052.jpg Edgar Link pending
moh09302018exhibit21053.jpg Edgar Link pending
moh09302018exhibit21054.jpg Edgar Link pending
moh09302018exhibit21055.jpg Edgar Link pending
moh09302018exhibit21056.jpg Edgar Link pending
moh09302018exhibit21057.jpg Edgar Link pending
moh09302018exhibit21058.jpg Edgar Link pending
moh09302018exhibit21059.jpg Edgar Link pending
moh09302018exhibit21060.jpg Edgar Link pending
moh09302018exhibit21061.jpg Edgar Link pending
moh09302018exhibit21062.jpg Edgar Link pending
moh09302018exhibit21063.jpg Edgar Link pending
moh09302018exhibit21064.jpg Edgar Link pending
moh09302018exhibit21065.jpg Edgar Link pending
moh09302018exhibit21066.jpg Edgar Link pending
moh09302018exhibit21067.jpg Edgar Link pending
molinalogo2016a26.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending